# SITAGLIPTIN
> **ANDA217979** · Abbreviated New Drug Application (Generic) · Sponsor: UMEDICA LABORATORIES PRIVATE LIMITED · Approved 2026-07-20
## Drug
- **FDA Application Number:** ANDA217979
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN
- **Generic name:** Sitagliptin
- **Active ingredients:** SITAGLIPTIN
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** UMEDICA LABORATORIES PRIVATE LIMITED
- **First approval:** 2026-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217979)
---
*MORVS · CC0 1.0*